PerpEquities

Equity · Healthcare

Samsung Biologics Co., Ltd. (SSBIOLOGICS) perpetual futures

SSBIOLOGICS perpetual futures on 1 crypto exchange – live perp price vs the stock, funding rate, open interest and where to trade SSBIOLOGICSUSDT.

Samsung Biologics provides contract development and manufacturing services for biopharmaceutical products, including cell line development, aseptic filling and lyophilization, plus biosafety, quality and analytical testing.

$1,002+0.4%
Open in terminal

Price chart

 

Use the left and right arrow keys to inspect points on the chart.

venue perp mark · Bitget (SSBIOLOGICS/USDT)
Auto: highest-volume live perp venueOpen in TradingView

Trading data

Perpetual market activity

1/1 live markets
Venues
1
Live markets
1/1
24h volume
$5.1K
Open interest
$40.3K
Best liquidity
$148.2K
Bitget
Tightest spread
+68.9 bps
Bitget
Highest volume
$5.1K
Bitget
Settlement mix
USDT · 1/1
Perp/spot vol.
0.00x
Spot volume $44.3M
OI / float
0.00%
Float $11.8B
Spot performance
1D-1.45%
5D-4.04%
1M-4.38%
6M-2.87%
YTD-19.49%
1Y-27.82%

Venue matrix

1 markets

Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.

Trade
BitgetTradeSSBIOLOGICS/USDTTrading$1,0020.0% APR
0.000% every 8h
+68.9 bps$148.2K$5.1K$40.3KUSDT20x

Tradability

Execution quality

Entry cost and depth per venue at $1k–$100k

Thin liquidity · 1 of 1 venues absorb $10k · Typical cost: +69.5 bps

Cheapest execution: Bitget · +69.5 bps

Taker execution estimate incl. approx. fees - maker fills are not guaranteed.

Best venues for this underlying

Best liquidity

SSBIOLOGICS

Tightest spread

SSBIOLOGICS

Highest volume

SSBIOLOGICS

Funding history

Stored venue snapshots by market

Company financials

Financials at a glance

Last report Q3 '26 · filed 2026-09-30 · next report 2027-01-27 · Updated 1m ago
All financials →

Valuation & key figures

Market cap
$48.5B
Updated 1m ago
Revenue
₩4.38T
Trailing 12 months
Revenue growth
–
Next fiscal year
Profit margin
41.1%
Net income / revenue, TTM
P/E
34.9×
P/S
14.9×
Price / sales, TTM
Peer P/E
45.4×
Similar listed perps
EV / EBITDA
25.9×
TTM
Free cash flow
₩1.45T
Trailing 12 months
Net income
₩1.8T
Trailing 12 months
Revenue estimate
–
Next fiscal year
Earnings
2027-01-27
Revenue est. $1.12B · Updated 1m ago
Dividend
–
No dividend
Revenue (TTM)₩4.38T-20.5% vs a year agoLast 4 quarters; bars = each quarter
Operating margin (TTM)43.4%+6.7 pp vs a year agoOperating income ₩1.9T
Net income (TTM)₩1.8T+12.9% vs a year agoAfter tax, incl. non-operating gains
Free cash flow (TTM)₩1.45T+95.3% vs a year agoCapex ₩769B
Diluted EPS (TTM)₩38,871.96+12.8% vs a year agoSum of the last 4 quarters
Net cash₩1.28T+81.6% vs a year agoCash + short-term investments - debt
  • Last report (2026-10-21): revenue beat by 9.7%, EPS missed by 13.8%Revenue ₩1.49T vs ₩1.36T expected (+9.7%); EPS ₩8,448.73 vs ₩9,799.29 (-13.8%).
  • Revenue growth slowing: -10.2% year on yearQ3 '26 revenue ₩1.49T, against an average of -9.1% over the four quarters before.
  • Operating margin 43.4% (TTM), +6.7 pp on a year agoOperating income grew -5.9% while revenue grew -20.5%.
  • 13.7% of pre-tax profit is non-operatingPre-tax income ₩2.2T vs operating income ₩1.9T (TTM). Gains on equity stakes and other one-off items lift net income and EPS - operating income is the cleaner measure of the business.

Revenue, operating income and growth

quarterly
In the full financialsIncome statement, balance sheet and cash flow (12 quarters / 10 years) · margins and cost structure · capital allocation and buybacks · valuation against the 5-year range · analyst estimates

Next catalyst

Catalysts

Earnings
2027-01-27
Revenue est. $1.12B · Updated 1m ago

No unusual perp activity right now.

Reference data

Market context

Reference market

Closed
Korea Exchange
Regular hours
CLOSED – CLOSED GMT+9
Next holiday
Dec 25, 2026 · Christmas

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 202629.10$4.1B+22%18
FY 202734.26$4.8B+16%22
FY 202838.73$5.3B+12%11
FY 202940.09$5.7B+7%13
FY 20300.00$6.4B+11%10
Q3 20267.29$1B-18%4
Source: FMP · Consensus

Company events

6
2027-01-27EarningsActual - / Estimate 11,137-
2026-10-21EarningsActual 8,449 / Estimate 9,799Miss
2026-07-23EarningsActual 8,768 / Estimate 9,356Miss
2026-04-22EarningsActual 9,925 / Estimate 9,545Beat
2026-01-21EarningsActual 10,935 / Estimate 11,295Miss
2025-10-30Stock split650391:1000000-

Peer comparison

Similar listed perps

Company data

Company intelligence

Updated: Nov 21, 2026, 06:04 PM UTC

Company profile

Sector
Healthcare
Industry
Biotechnology
Chief executive
John Chongbo Rim
Employees
5,455
IPO date
Nov 11, 2016
Country
KR
Exchange
Korea Exchange
Website
Altman Z-scorei11.87
Piotroski scorei8/9
Overall ratingiC-
Owner earningsi₩110.61B₩2,373.45 per share

Rating factors

Return on equityi
1/5
Return on assetsi
1/5
Debt to equityi
1/5
Price to earningsi
1/5
Price to booki
1/5
Market cap history
₩63.15T-12.0%Aug 2026 – Nov 2026
₩55.6T₩64.21T₩72.82THigh: ₩72.82T · 2026-08-24Low: ₩55.6T · 2026-10-12Latest: ₩63.15T · 2026-11-20Aug 2026Sep 2026Oct 2026Nov 2026
Latest: ₩63.15T · 2026-11-20High: ₩72.82T · 2026-08-24Low: ₩55.6T · 2026-10-12
Largest fund holders
FundWeightShares held
EWY1.05%206.6K
VXUS0.03%175.4K
WWK0.57%156.3K
IEMG0.1%134.8K
102780.KS6.71%116.2K
VEA0.04%115.9K
069500.KS0.57%82.2K
FEMKX0.67%74.9K
364970.KS25.14%46.4K
EIMI.L0.1%38.9K
EIMU DE0.07%37.2K
FLRK.L0.89%35.1K

Analyst track record

How the analysts covering SSBIOLOGICS have done: ratings, price-target accuracy and the measured reaction after their calls.

12 months3 years
Ratings00
Analysts00
Buy / hold / sell––
Upgrades / downgrades / initiations0 / 0 / 00 / 0 / 0
Price targets hit / missed––
Avg. return after a rating (TipRanks)––
Best / worst call– / –– / –

After buy calls on this stock: not enough measured cases yet

TipRanks data · computed Nov 21, 2026 · 0 ratings

Frequently asked questions

Where can I trade SSBIOLOGICS perpetual futures?

Samsung Biologics Co., Ltd. (SSBIOLOGICS) perpetual futures trade on one crypto venue: Bitget. PerpEquities shows its live price, funding rate, open interest and liquidity.

Can I trade SSBIOLOGICS around the clock?

Yes. Unlike the underlying stock, SSBIOLOGICS perpetuals trade 24/7 — including weekends and outside regular market hours.

What is the funding rate on SSBIOLOGICS perpetuals?

Right now the SSBIOLOGICS perp funding rate is 0.0% annualized (one venue). A positive rate means longs pay shorts. PerpEquities shows the live rate and its history.

How does the SSBIOLOGICS perp price compare to the Samsung Biologics Co., Ltd. stock?

The venue-median SSBIOLOGICS perp mark is $1K versus a reference stock price of $1K, a basis of 0.0%. Perps follow the stock through an index price; the gap widens when funding or liquidity diverge between venues.

What is a SSBIOLOGICS perpetual future?

A SSBIOLOGICS perpetual is a derivative that tracks the price of Samsung Biologics Co., Ltd. with no expiry date. It lets you take long or short exposure to Samsung Biologics Co., Ltd. on crypto venues, around the clock.

What is SSBIOLOGICSUSDT perpetual?

SSBIOLOGICSUSDT is the symbol most crypto exchanges use for the Samsung Biologics Co., Ltd. perpetual settled in USDT (Tether). It tracks the SSBIOLOGICS share price through an index, trades 24/7 with leverage and never expires.

Embed this asset

SSBIOLOGICS perpetuals · perpequities.comSSBIOLOGICS perpetuals · perpequities.com
<a href="https://perpequities.com/stocks/ssbiologics-perp"><img src="https://perpequities.com/badge/ssbiologics-perp.svg" width="240" height="64" alt="SSBIOLOGICS perpetuals · perpequities.com" loading="lazy"></a>

Next step

Stay on top of SSBIOLOGICS perps

Signals with a track record

Analysts who hit 70%+ of their targets on the perps we track, congress buys over $500k, 13F positions over $5M, funding spreads that have paid for days. Every post shows the evidence. Free, no sign-up.

Join on Telegram

Weekly digest by email

The listings, funding and moves that matter for SSBIOLOGICS — one email every Sunday.

Watchlist and alerts

Price and funding alerts for SSBIOLOGICS, via push or Telegram.

Set an alert

Follow the live feed

Daily movers, new listings and funding extremes as they happen.

Follow on X